Literature DB >> 26739813

Thiazolidine: A Potent Candidate for Central Nervous Systems Diseases.

Radhe Shyam Bahare1, Swastika Ganguly, Ritesh Agrawal, Subodh Narayan Dikshit.   

Abstract

Thiazolidines are multifaceted molecules and exhibit varied types of biological activities, and also showed anticonvulsants and antidepressants activity. It is the diversified class of heterocyclic compounds. Thiazolidinediones (TZD) has been shown beneficial action in various CNS diseases. The significant mechanism of TZD-induced neuroprotection useful in prevention of microglial activation and cytokine that is responsible for inflammatory condition and chemokine expression. At the molecular level TZDs were also responsible to prevent the activation of pro-inflammatory transcription factors as well as promoting the anti-oxidant mechanisms in the injured CNS. Important SAR, molecular mechanism and potent biological activities with special references to central nervous system are discussed in this article. Various investigations suggest that this moiety pave the way for design and discovery of new drug candidates.

Entities:  

Year:  2016        PMID: 26739813

Source DB:  PubMed          Journal:  Cent Nerv Syst Agents Med Chem        ISSN: 1871-5249


  2 in total

1.  Thiazolidinedione Derivatives: In Silico, In Vitro, In Vivo, Antioxidant and Anti-Diabetic Evaluation.

Authors:  Manal Y Sameeh; Manal M Khowdiary; Hisham S Nassar; Mahmoud M Abdelall; Hamada H Amer; Abdelaaty Hamed; Ahmed A Elhenawy
Journal:  Molecules       Date:  2022-01-27       Impact factor: 4.411

2.  Discovery Potent of Thiazolidinedione Derivatives as Antioxidant, α-Amylase Inhibitor, and Antidiabetic Agent.

Authors:  Manal Y Sameeh; Manal M Khowdiary; Hisham S Nassar; Mahmoud M Abdelall; Suliman A Alderhami; Ahmed A Elhenawy
Journal:  Biomedicines       Date:  2021-12-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.